Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

ClinicalTrials.gov ID: NCT07361497

Public ClinicalTrials.gov record NCT07361497. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Oct 20, 2026, 3:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Compared to Durvalumab in Participants With Unresectable Stage III NSCLC Without Progression After Platinum-based Concurrent Chemoradiation Therapy.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A study to evaluate Pumitamig versus Durvalumab following concurrent chemoradiation therapy in participants with unresectable stage III Non-small Cell Lung Cancer (NSCLC)

Study identification

NCT ID
NCT07361497
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
850 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 16, 2026 (Actual)
Primary completion
Sep 18, 2030 (Estimated)
Completion
Jan 13, 2034 (Estimated)
Last update posted
Sep 30, 2026

2026 – 2034

United States locations

U.S. sites
38
U.S. states
19
U.S. cities
35
Facility City State ZIP Site status
Southern Cancer Center Pc Daphne Alabama 36526 Recruiting
Intermountain Health Cancer Center Lutheran Hospital Golden Colorado 80401 Recruiting
Medical Oncology Hematology Consultants, PA Newark Delaware 19713 Recruiting
Local Institution - 0711 Ocala Florida 34474 Not yet recruiting
Local Institution - 0935 Plantation Florida 33322 Not yet recruiting
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital Marietta Georgia 30060 Recruiting
University of Chicago Medical Center Chicago Illinois 60637 Recruiting
Endeavor Health Evanston Illinois 60201 Recruiting
Illinois Cancer Care Peoria Illinois 61615 Recruiting
Fort Wayne Medical Oncology and Hematology Fort Wayne Indiana 46804 Recruiting
University of Kentucky Chandler Medical Center Lexington Kentucky 40536 Recruiting
Local Institution - 0603 Boston Massachusetts 02114-2621 Not yet recruiting
Karmanos Cancer Institute Detroit Michigan 48201 Recruiting
Minnesota Oncology Hematology Maple Grove Minnesota 55369 Recruiting
Allina Health Cancer Institute - Abbott Northwestern Hospital Minneapolis Minnesota 55407 Recruiting
Missouri Cancer Associates Columbia Missouri 65201 Recruiting
Memorial Sloan Kettering Cancer Center New York New York 10065 Recruiting
Local Institution - 0339 Westbury New York 11590 Withdrawn
Optum Medical Care, PC Westbury New York 11590 Recruiting
Novant Health Pharmacy Oncology Specialists Winston-Salem North Carolina 27103 Recruiting
Akron General Medical Center Akron Ohio 44302 Recruiting
The Christ Hospital Cincinnati Ohio 45219 Recruiting
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 Recruiting
Cleveland Clinic Cleveland Ohio 44195 Recruiting
Cleveland Clinic - Hillcrest Hospital Mayfield Heights Ohio 44124 Recruiting
Oncology Associates Of Oregon, Pc Eugene Oregon 97401 Recruiting
Northwest Cancer Specialists, P.C. Happy Valley Oregon 97015 Recruiting
SCRI Oncology Partners Nashville Tennessee 37203 Recruiting
Tennessee Oncology Nashville Tennessee 37203 Recruiting
Texas Oncology - Amarillo Cancer Center Amarillo Texas 79124 Recruiting
Texas Oncology-Austin Central Austin Texas 78731 Recruiting
Texas Oncology Denton Texas 76210 Recruiting
The Center For Cancer And Blood Disorders Fort Worth Texas 76104 Recruiting
The University of Texas-MD Anderson Cancer Center Houston Texas 77030 Recruiting
Texas Oncology - San Antonio Medical Center San Antonio Texas 78229 Recruiting
Texas Oncology - Northeast Texas Tyler Texas 75702 Recruiting
Blue Ridge Cancer Care Christiansburg Virginia 24073 Recruiting
Virginia Oncology Associates Norfolk Virginia 23502 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 222 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07361497, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 30, 2026 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07361497 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →